CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,587,910 | -64.2% | 6,809,404 | -44.6% | 0.74% | -62.7% |
| Q2 2023 | $105,022,537 | -14.6% | 12,297,721 | -8.1% | 1.98% | -28.8% |
| Q1 2023 | $122,971,886 | -10.0% | 13,381,054 | 0.0% | 2.78% | +0.5% |
| Q4 2022 | $136,620,561 | -30.6% | 13,381,054 | 0.0% | 2.77% | -34.1% |
| Q3 2022 | $196,969,000 | +37.2% | 13,381,054 | 0.0% | 4.20% | +9.8% |
| Q2 2022 | $143,578,000 | -0.5% | 13,381,054 | 0.0% | 3.83% | +21.6% |
| Q1 2022 | $144,248,000 | -8.0% | 13,381,054 | +39.3% | 3.15% | +13.9% |
| Q4 2021 | $156,787,000 | -23.8% | 9,607,028 | 0.0% | 2.76% | -3.0% |
| Q3 2021 | $205,686,000 | – | 9,607,028 | – | 2.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |